Mature miRNA: hsa-miR-383-3p

Mature miRNA

miRNA Name hsa-miR-383-3p
miRNA Sequence 5' - acagcacugccuggucaga - 3' (length = 19)
Predicted Targets miRDB
Validated Targets TarBase
miRBase ID MIMAT0026485

Precursor miRNA

Precursor Name hsa-mir-383
Genomic Location chr8:14853438-14853510 (-); nearby genomic features
NCBI GENE ID 494332
miRBase ID MI0000791
Precursor Sequence 
   -c  a      aa    a        uug   gga
cuc  uc gaucag  ggug uuguggcu   ggu   u
|||  || ||||||  |||| ||||||||   |||   
gag  ag cugguc  ucac gacaccga   cua   a
   aa  a      cg    -        ---   auu

References

  • LncRNA TMPO-AS1 Promotes Triple-Negative Breast Cancer by Sponging miR-383-5p to Trigger the LDHA Axis. Vats P, Singh J, Srivastava SK, Kumar A, Nema R. Asian Pac J Cancer Prev. 2024 Aug 1;25(8):2929-2944.

  • Horizontal transfer of miR-383 sensitise cells to cisplatin by targeting VEGFA-Akt signalling loop. Raji GR, Poyyakkara A, Sruthi TV, Edatt L, Haritha K, Shankar SS, Kumar VBS. Mol Biol Rep. 2024 Feb 8;51(1):286.

  • MiR-383 sensitizes osteosarcoma cells to bortezomib treatment via down-regulating PSMB5. Wang H, Bai C, Dang X, Wang H. Mol Biol Rep. 2024 Jan 22;51(1):170.

  • LINC01485 contributes to colorectal cancer progression by targeting miR-383-5p/KRT80 axis. Gao X, Wang G, Zhang M, Zhang X, Zhang S, Long H. Environ Toxicol. 2024 Jan;39(1):398-408.

  • mirna-383-5p Functions as an Anti-oncogene in Glioma through the Akt/mTOR Signaling Pathway by Targeting VEGFA. Liu Y, Wang Z, Tang Z, Fu Y, Wang L. Curr Cancer Drug Targets. 2024;24(4):463-475.

  • Knockdown of circ-ADAM9 inhibits malignant phenotype and enhances radiosensitivity in breast cancer cells via acting as a sponge for miR-383-5p. Song P, Wu J, Chen J, Wang F, Chen J, Wang G. Strahlenther Onkol. 2023 Jan;199(1):78-89.

  • E2F7 enhances hepatocellular carcinoma growth by preserving the SP1/SOX4/Anillin axis via repressing miRNA-383-5p transcription. Hao F, Wang N, Zhang Y, Xu W, Chen Y, Fei X, Wang J. Mol Carcinog. 2022 Nov;61(11):975-988.

  • Significant role of long non-coding RNA MALAT1 in deep vein thrombosis via the regulation of vascular endothelial cell physiology through the microRNA-383-5p/BCL2L11 axis. Wang H, Lin S, Yang Y, Zhao M, Li X, Zhang L. Bioengineered. 2022 May;13(5):13728-13738.

  • Circ_0005231 promotes the progression of esophageal squamous cell carcinoma via sponging miR-383-5p and regulating KIAA0101. Sun Z, Zhang S, Zhang N, Wang J, Wang J, Liu J. Thorac Cancer. 2022 Jun;13(12):1751-1762.

  • miR-383 Regulates Hepatic Lipid Homeostasis and Response to Dengue Virus Infection. Ahmed N, Ahmed N, Pezacki JP. ACS Infect Dis. 2022 May 13;8(5):928-941.

  • MiR-383-5p promotes apoptosis of ovarian granulosa cells by targeting CIRP through the PI3K/AKT signaling pathway. Li Y, Wu X, Miao S, Cao Q. Arch Gynecol Obstet. 2022 Aug;306(2):501-512.

  • miR-383-5p inhibits human malignant melanoma cells function via targeting CENPF. Xu H, Zhu X, Shi L, Lin N, Li X. Reprod Biol. 2021 Sep;21(3):100535.

  • MicroRNA-383-5p regulates osteogenic differentiation of human periodontal ligament stem cells by targeting histone deacetylase 9. Ma L, Wu D. Arch Oral Biol. 2021 Sep;129:105166.

  • Long non‑coding RNA MIR4435‑2HG promotes the progression of head and neck squamous cell carcinoma by regulating the miR‑383‑5p/RBM3 axis. Wang S, Chen X, Qiao T. Oncol Rep. 2021 Jun;45(6):99.

  • Translational control of Bcl-2 promotes apoptosis of gastric carcinoma cells. Tao S, Gu J, Wang Q, Zheng L. BMC Cancer. 2021 Jan 5;21(1):12.

  • MicroRNA -383-5p restrains the proliferation and migration of breast cancer cells and promotes apoptosis via inhibition of PD-L1. Azarbarzin S, Hosseinpour-Feizi MA, Banan Khojasteh SM, Baradaran B, Safaralizadeh R. Life Sci. 2021 Feb 15;267:118939.

  • miR-383 ameliorates high glucose-induced β-cells apoptosis and hyperglycemia in high-fat induced diabetic mice. Cheng X, Huang Y, Yang P, Bu L. Life Sci. 2020 Dec 15;263:118571.

  • Identification of regulatory mRNA and microRNA for differentiation into cementoblasts and periodontal ligament cells. Iwata T, Mizuno N, Nagahara T, Kaneda-Ikeda E, Kajiya M, Kitagawa M, Takeda K, Yoshioka M, Yagi R, Takata T, Kurihara H. J Periodontal Res. 2021 Jan;56(1):69-82.

  • LINC00162 participates in the pathogenesis of diabetic nephropathy via modulating the miR-383/HDAC9 signalling pathway. Fan W, Wen X, Zheng J, Wang K, Qiu H, Zhang J, Su F. Artif Cells Nanomed Biotechnol. 2020 Dec;48(1):1047-1054.

  • Expression and clinical diagnostic value of miR-383 in patients with severe preeclampsia. Li T, Zhou B, He Y, Liu J, Li Y. Cell Mol Biol (Noisy-le-grand). 2020 Jun 5;66(3):92-100.

    • There are 64 references associated with hsa-miR-383-3p. Click here to see the complete list in PubMed.